Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

CRISPR/Cas for diatom gene editing: pitfalls, solutions, and emerging tools.

Created on 19 Nov 2026

Authors

Mirna Sekulić, Arthur Cleyman, Wim Vyverman, Lieven De Veylder

Published in

Plant physiology. Nov 18, 2026. Epub Nov 18, 2026.

Abstract

Diatoms are ecologically important unicellular photosynthetic microalgae that are of increasing interest in biotechnology. Remarkably, probably due to their complex evolutionary history, diatoms hold many species-specific genes, most of which have an unknown function. The development of CRISPR/Cas-based genome editing techniques offers a unique opportunity to elucidate the function of these genes and to introduce novel traits of interest. Just as Arabidopsis thaliana serves as the reference model for higher plant genetics, Phaeodactylum tricornutum has emerged as the principal model for diatom genome editing. Its CRISPR/Cas toolkit comprises Cas9, Cas12a, CRISPR interference, and genome-wide screens. However, progress remains uneven. Methods optimized for P. tricornutum are not readily transferable to other diatoms, which often require species-specific adjustments. In this review, we discuss the current state of CRISPR/Cas-mediated editing in diatoms and, where relevant, compare it with the more well-established field of plant genome editing. We argue that extending these tools is essential to understand diatom biology and realize their full biotechnological potential.

PMID:
43050583
Bibliographic data and abstract were imported from PubMed on 19 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement